Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Noveltea is a premium alcoholic tea brand launched in Fenwick in April 2017. The company's products are vegan, gluten-free and low in sugar, and manufactured in minimalistic & up-cyclable lifestyle packaging. Thanks to its low-Alcohol by volume (ABV) portfolio, the brand has sold 350,000 bottles since its launch in 2017. The company experienced more than £100,000 worth of sales in April 2020 despite COVID-19 due to smart e-commerce channel utilisation. In 2020, the size of the global alcoholic drinks market is $1.587 trillion and is forecasted to grow by 3.5% (CAGR) over the next three years. The brand aims to become a major contender in this segment and grow its business. The company use the investment to focus on its core markets in the UK, Germany, and China, and enter the USA by 2020.
days to go:
Expired
investment:
£558,845
PCL Health is a Business-to-Business (B2B) Software-as-a-Service (SaaS) entity that aims to bring hospital-level care to anyone remotely. It asserts that the correct use of remote monitoring can reduce mortality by up to 45%. PCL Health intends to become a contender in the remote healthcare market that is set to touch $30 billion by 2023. It has developed CE rated medical-grade devices that use health algorithms combined with sensors and its proprietary range of apps to allow family members to proactively monitor the health of their loved ones, alongside carers and doctors, remotely. PCL Health has completed two pilots with 65 people and received a Letter Of Intent (LOI) from a National Health Service (NHS) Trust for a clinical trial. It won the 'Innovative Startup' competition at the 2019 Healthcare Unblocked event. PCL Health will use the investment for technology enhancement, running further pilot studies, and working capital.
days to go:
Expired
investment:
£394,680
The Saucy Affair Raw Sauces creates a new range of fresh, convenient, and healthy foods made of real ingredients. The company aims at relaunching 6 tried and tested products in retail, 3 dressings, and 3 sauces. The Saucy Affair Raw Sauces has targeted and engaged with 3 key revenue streams, that are: UK Retail & Wholesale, EU Food Service and Retail, and UK Food Service. With the proceeds, the company will employ an experienced team, implement its robust PR, Marketing, and Retail Activation Plan.
days to go:
Expired
investment:
£130,724
Cranes develop acoholic, cranberry flavoured drinks. Currently their product range consists of 3 different variations of cranberry cider and also a cranberry liqueur. Current stockists include the online supermarket Ocado, as well as many other local shops and bars.
days to go:
Expired
investment:
£194,634
Intelligent Health aim to get the whole community active by providing games and incentives such as ''beat the street''. By providing schools and communities with friendly competition to walk and cycle more by tapping their cards on ''beat boxes'', and with prizes and league tables on offer, Intelligent health are bringing communities together.
days to go:
Expired
investment:
£700,000
Ready Burger (RB) states that it has created the UK's first scalable, value-driven, entirely plant-based Quick Service Restaurant (QSR) brand. RB claims that it has mastered the science behind the taste and texture of plant-based foods to make them indistinguishable from their non-veg counterparts. It further points out that its final products use up to 92% lesser greenhouse gases, and require up to 70% lesser water than competitor brands. RB argues that its meals cater for vegetarians, vegans, meat lovers, and people preferring Halal or Kosher foods. RB offers fast-food classics and has partnered with a global plant-based food manufacturer. RB asserts that its ergonomically designed kitchens enable it to produce 1000s of items a day, that are in turn, serviced from its central distribution centre. RB's integrated web-app ordering, in-store ordering kiosks and an innovative delivery solution allow customers to have their food in under 30 minutes. RB says it will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£1,998,549
